Article info

Original research
Potent ex vivo armed T cells using recombinant bispecific antibodies for adoptive immunotherapy with reduced cytokine release

Authors

  1. Correspondence to Dr Nai-Kong V Cheung; cheungn{at}mskcc.org
View Full Text

Citation

Park JA, Santich BH, Xu H, et al
Potent ex vivo armed T cells using recombinant bispecific antibodies for adoptive immunotherapy with reduced cytokine release

Publication history

  • Accepted March 17, 2021
  • First published May 13, 2021.
Online issue publication 
May 13, 2021
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.